Opella Healthcare Group Sas, A Sanofi Company
Clinical trials sponsored by Opella Healthcare Group Sas, A Sanofi Company, explained in plain language.
-
Can Pre-Treating with allergy pills stop ragweed misery?
Symptom relief CompletedThis study looked at whether taking the allergy drug fexofenadine (180 mg) for two days before ragweed season starts can prevent or reduce symptoms like runny nose, sneezing, and itchy eyes. 95 adults with ragweed allergies participated. The goal was to see if early treatment hel…
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated May 26, 2026 10:15 UTC
-
New allergy pill tested: can you take it without water?
Knowledge-focused CompletedThis study tested a new version of the allergy drug fexofenadine (Allegra) to see how well it is absorbed when taken with or without water, compared to the current coated tablet taken with water. Twenty-five healthy adults each received six different treatments in random order un…
Phase: PHASE1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated May 26, 2026 10:29 UTC
-
New Magne-B6 tablet tested against liquid version in healthy volunteers
Knowledge-focused CompletedThis study tested a new tablet form of Magne-B6 (magnesium and vitamin B6) against the current liquid version in 24 healthy adults. The goal was to see how well the body absorbs the new tablet. Participants took both forms at different times, and researchers measured magnesium an…
Phase: PHASE1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated May 26, 2026 08:19 UTC